Trelegy ellipta 200-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FQX64
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,594
Award facts
- Contract value 100% obligated
- $10,593.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalant medication in a 60-dose configuration. This is a firm fixed price delivery order valued at $10,593.81, with an ultimate completion date of June 3, 2025. The contract was not set-aside and represents a competitive award to the vendor. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026 and serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp's extensive federal contracting portfolio with the DLA demonstrates its critical role as a pharmaceutical distributor for the Department of Defense medical supply chain. The company supplies a broad range of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for Trelegy Ellipta, a combination respiratory medication used in treatment of chronic obstructive pulmonary disease, exemplifies the company's ongoing support of military and veteran healthcare systems through competitive federal procurement mechanisms.
Quick answers
Who was awarded contract SPE2DB25FQX64?
SPE2DB25FQX64 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FQX64 worth?
The government has obligated $10,594 on SPE2DB25FQX64.
Is contract SPE2DB25FQX64 an order under another contract?
Yes. SPE2DB25FQX64 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQX64 competed?
The extent of competition for SPE2DB25FQX64 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award